Lucy Scientific Goes After Pasithea Therapeutics Common Shares For A ‘142% Premium’ Deal – Pasithea Therapeutics (NASDAQ:KTTA), Lucy Scientific Discovery (NASDAQ:LSDI)
Health Canada-licensed psychedelics producer Lucy Scientific Discovery LSDI announced it has sent a proposal to biotech business Pasithea Therapeutics Corp. KTTA to acquire each share of its common stock. Pasithea’s business development plan within treatments for mental health conditions includes ketamine-assisted therapy. Lucy is offering to pay $0.60 in cash plus $0.25 in Lucy stock […]